Effectiveness and safety of dolutegravir two‐drug regimens in virologically suppressed people living with HIV: a systematic literature review and meta‐analysis of real‐world evidence

OBJECTIVES: Dolutegravir (DTG) is widely recommended within three‐drug regimens. However, similar efficacy and tolerability have also been achieved with DTG within two‐drug regimens in clinical trials. This study evaluated the real‐world effectiveness and discontinuations in people living with HIV‐1...

Descripción completa

Detalles Bibliográficos
Autores principales: Punekar, Y S, Parks, D, Joshi, M, Kaur, S, Evitt, L, Chounta, V, Radford, M, Jha, D, Ferrante, S, Sharma, S, Van Wyk, J, de Ruiter, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248313/
https://www.ncbi.nlm.nih.gov/pubmed/33529489
http://dx.doi.org/10.1111/hiv.13050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248313/
https://www.ncbi.nlm.nih.gov/pubmed/33529489
http://dx.doi.org/10.1111/hiv.13050

Ejemplares similares